Deerfield Management as of March 31, 2017
Portfolio Holdings for Deerfield Management
Deerfield Management holds 105 positions in its portfolio as reported in the March 2017 quarterly 13F filing
Company (Ticker) |
Portfolio Weight |
Valued At |
Change in Shares |
Share Count |
Share Price |
---|---|---|---|---|---|
Avexis | 6.6 | $170M | 2.2M | 76.03 | |
Horizon Pharma | 6.2 | $162M | 11M | 14.78 | |
NxStage Medical | 3.9 | $101M | 3.7M | 26.83 | |
Mylan Nv | 3.8 | $97M | 2.5M | 38.99 | |
Horizon Pharma Plc convertible security | 3.2 | $83M | 90M | 0.92 | |
Gilead Sciences (GILD) | 3.1 | $82M | 1.2M | 67.92 | |
Dbv Technologies S A | 2.4 | $61M | 1.7M | 35.22 | |
Isis Pharmaceuticals Inc Del note 1.000%11/1 | 2.3 | $60M | 63M | 0.96 | |
Portola Pharmaceuticals | 2.2 | $57M | 1.5M | 39.19 | |
Blueprint Medicines (BPMC) | 2.1 | $55M | 1.4M | 39.99 | |
Anthem (ELV) | 2.0 | $53M | 318k | 165.38 | |
Gw Pharmaceuticals Plc ads | 2.0 | $52M | 426k | 120.94 | |
Endologix Inc note 2.250%12/1 | 1.9 | $49M | 51M | 0.96 | |
Kempharm Inc note 5.500% 2/0 | 1.8 | $46M | 75M | 0.61 | |
Centene Corporation (CNC) | 1.7 | $43M | 604k | 71.26 | |
Lannett Company | 1.6 | $41M | 1.9M | 22.35 | |
Endologix, Inc. 3.25% 11/01/2020 | 1.6 | $40M | 41M | 0.99 | |
Intercept Pharmas conv | 1.5 | $40M | 43M | 0.93 | |
Flamel Technologies Sa | 1.5 | $39M | 4.1M | 9.68 | |
Trn 4% 04/01/45 | 1.5 | $39M | 48M | 0.81 | |
Editas Medicine (EDIT) | 1.5 | $38M | 1.7M | 22.32 | |
Nevro (NVRO) | 1.5 | $38M | 403k | 93.70 | |
Molina Healthcare Inc conv | 1.4 | $37M | 35M | 1.06 | |
Aerie Pharmaceuticals | 1.4 | $36M | 796k | 45.35 | |
Aetna | 1.3 | $34M | 267k | 127.55 | |
McKesson Corporation (MCK) | 1.3 | $34M | 229k | 148.26 | |
Nevro Corp note 1.750% 6/0 | 1.3 | $34M | 28M | 1.22 | |
Mallinckrodt Pub | 1.2 | $33M | 729k | 44.57 | |
Vanda Pharmaceuticals (VNDA) | 1.2 | $32M | 2.3M | 14.00 | |
eHealth (EHTH) | 1.2 | $32M | 2.6M | 12.04 | |
Array Biopharma Inc note 3.000% 6/0 | 1.2 | $32M | 22M | 1.43 | |
Loxo Oncology | 1.2 | $32M | 753k | 42.08 | |
Xencor (XNCR) | 1.2 | $31M | 1.3M | 23.92 | |
Walgreen Boots Alliance (WBA) | 1.1 | $30M | 356k | 83.05 | |
Universal American | 1.1 | $28M | 2.8M | 9.97 | |
BioCryst Pharmaceuticals (BCRX) | 1.0 | $26M | 3.1M | 8.40 | |
Ascendis Pharma A S (ASND) | 1.0 | $26M | 929k | 28.00 | |
Syros Pharmaceuticals | 1.0 | $26M | 1.6M | 15.93 | |
Epizyme | 0.9 | $24M | 1.4M | 17.15 | |
Wright Med Group Inc note 2.000% 2/1 | 0.9 | $24M | 20M | 1.20 | |
Audentes Therapeutics | 0.9 | $24M | 1.4M | 17.04 | |
Anaptysbio Inc Common (ANAB) | 0.9 | $24M | 846k | 27.75 | |
Galapagos Nv- (GLPG) | 0.9 | $22M | 260k | 86.19 | |
Advanced Accelerat spon ads each rep 2 ord | 0.8 | $21M | 523k | 39.86 | |
Axogen (AXGN) | 0.7 | $19M | 1.8M | 10.45 | |
Fluidigm Corporation convertible cor | 0.7 | $19M | 28M | 0.67 | |
Recro Pharma | 0.7 | $18M | 2.1M | 8.74 | |
Healthways Inc note 1.500% 7/0 | 0.7 | $18M | 12M | 1.54 | |
Aac Holdings | 0.7 | $17M | 2.0M | 8.53 | |
Valeant Pharmaceuticals Int | 0.6 | $17M | 1.5M | 11.03 | |
Cytomx Therapeutics (CTMX) | 0.6 | $16M | 943k | 17.27 | |
Selecta Biosciences | 0.6 | $15M | 1.1M | 14.32 | |
Spark Therapeutics | 0.6 | $15M | 283k | 53.34 | |
Neos Therapeutics | 0.6 | $15M | 2.1M | 7.20 | |
Humana (HUM) | 0.6 | $14M | 69k | 206.14 | |
Impax Laboratories Inc conv | 0.5 | $14M | 17M | 0.82 | |
Invuity | 0.5 | $13M | 1.7M | 7.95 | |
Wave Life Sciences (WVE) | 0.5 | $13M | 472k | 27.50 | |
Akari Therapeutics | 0.5 | $13M | 1.2M | 11.07 | |
Aclaris Therapeutics (ACRS) | 0.4 | $11M | 375k | 29.82 | |
Nivalis Therapeutics | 0.4 | $11M | 3.7M | 2.92 | |
Ardelyx (ARDX) | 0.4 | $11M | 842k | 12.65 | |
Jounce Therapeutics | 0.4 | $10M | 469k | 21.99 | |
Array BioPharma | 0.4 | $10M | 1.1M | 8.94 | |
Tesaro | 0.4 | $10M | 66k | 153.86 | |
Steadymed | 0.4 | $10M | 1.8M | 5.80 | |
Bluebird Bio (BLUE) | 0.4 | $9.7M | 107k | 90.90 | |
Oxford Immunotec Global | 0.4 | $9.5M | 617k | 15.49 | |
Allscripts Healthcare So conv | 0.4 | $9.7M | 9.7M | 1.00 | |
Dex (DXCM) | 0.4 | $9.4M | 111k | 84.73 | |
Glaukos (GKOS) | 0.4 | $9.2M | 180k | 51.30 | |
Globus Med Inc cl a (GMED) | 0.3 | $9.1M | 308k | 29.62 | |
Sage Therapeutics (SAGE) | 0.3 | $8.7M | 122k | 71.07 | |
Axovant Sciences | 0.3 | $8.5M | 568k | 14.94 | |
Alimera Sciences | 0.3 | $8.2M | 5.9M | 1.40 | |
Myovant Sciences | 0.3 | $8.3M | 705k | 11.74 | |
Tg Therapeutics (TGTX) | 0.3 | $8.2M | 700k | 11.65 | |
Sierra Oncology | 0.3 | $7.6M | 5.0M | 1.53 | |
Nanostring Technologies (NSTGQ) | 0.3 | $7.0M | 352k | 19.87 | |
Essa Pharma | 0.3 | $6.6M | 2.1M | 3.12 | |
Infinity Pharmaceuticals (INFIQ) | 0.2 | $6.4M | 2.0M | 3.23 | |
Kite Pharma | 0.2 | $6.4M | 81k | 78.49 | |
Myokardia | 0.2 | $5.6M | 425k | 13.15 | |
Kempharm | 0.2 | $5.3M | 1.1M | 4.90 | |
Five Prime Therapeutics | 0.2 | $5.0M | 138k | 36.15 | |
Sangamo Biosciences (SGMO) | 0.2 | $4.4M | 838k | 5.20 | |
Acorda Therap note 1.75% 6/15 | 0.2 | $4.3M | 5.0M | 0.85 | |
Foamix Pharmaceuticals | 0.2 | $4.0M | 817k | 4.95 | |
Ra Pharmaceuticals | 0.1 | $3.8M | 178k | 21.29 | |
Aralez Pharmaceuticals | 0.1 | $3.5M | 1.6M | 2.14 | |
BioScrip | 0.1 | $3.4M | 2.0M | 1.70 | |
Agile Therapeutics | 0.1 | $3.1M | 972k | 3.20 | |
Genocea Biosciences | 0.1 | $2.9M | 479k | 6.09 | |
Adeptus Health Inc-class A | 0.1 | $2.9M | 1.6M | 1.80 | |
Scynexis | 0.1 | $2.9M | 1.0M | 2.76 | |
CAS Medical Systems | 0.1 | $2.6M | 1.8M | 1.45 | |
pSivida | 0.1 | $2.6M | 1.5M | 1.72 | |
Proteon Therapeutics | 0.1 | $2.3M | 1.3M | 1.75 | |
Tivity Health | 0.1 | $2.2M | 76k | 29.11 | |
Voyager Therapeutics (VYGR) | 0.1 | $1.6M | 118k | 13.24 | |
Threshold Pharmaceuticals | 0.1 | $1.3M | 2.2M | 0.57 | |
Streamline Health Solutions | 0.0 | $676k | 663k | 1.02 | |
Corvus Pharmaceuticals (CRVS) | 0.0 | $767k | 37k | 20.77 | |
Syndax Pharmaceuticals (SNDX) | 0.0 | $523k | 38k | 13.72 | |
Obalon Therapeutics | 0.0 | $224k | 21k | 10.69 |